Hair loss under the microscope: new study observes women on fibroid drug
NCT ID NCT06058728
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 25 times
Summary
This study was designed to observe hair loss in women with uterine fibroids who are taking the approved drug Oriahnn. Researchers planned to track how many women experience hair thinning, when it starts, and if it goes away. The study was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UTERINE FIBROIDS (UF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dorsata /ID# 252675
Arlington, Virginia, 22201-5330, United States
Conditions
Explore the condition pages connected to this study.